company background image
ASTH logo

Astrana Health NasdaqCM:ASTH Stock Report

Last Price

US$33.70

Market Cap

US$1.7b

7D

-10.4%

1Y

-11.2%

Updated

22 Dec, 2024

Data

Company Financials +

Astrana Health, Inc.

NasdaqCM:ASTH Stock Report

Market Cap: US$1.7b

ASTH Stock Overview

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. More details

ASTH fundamental analysis
Snowflake Score
Valuation3/6
Future Growth5/6
Past Performance5/6
Financial Health4/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

US$64.50
FV
47.8% undervalued intrinsic discount
24.41%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
3 days ago author updated this narrative

Astrana Health, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Astrana Health
Historical stock prices
Current Share PriceUS$33.70
52 Week HighUS$63.20
52 Week LowUS$33.44
Beta1.14
1 Month Change-19.97%
3 Month Change-40.91%
1 Year Change-11.15%
3 Year Change-52.43%
5 Year Change80.70%
Change since IPO210.89%

Recent News & Updates

Recent updates

Is Now An Opportune Moment To Examine Astrana Health, Inc. (NASDAQ:ASTH)?

Dec 12
Is Now An Opportune Moment To Examine Astrana Health, Inc. (NASDAQ:ASTH)?

Impressive Earnings May Not Tell The Whole Story For Astrana Health (NASDAQ:ASTH)

Nov 22
Impressive Earnings May Not Tell The Whole Story For Astrana Health (NASDAQ:ASTH)

Astrana Health, Inc.'s (NASDAQ:ASTH) 33% Cheaper Price Remains In Tune With Earnings

Nov 18
Astrana Health, Inc.'s (NASDAQ:ASTH) 33% Cheaper Price Remains In Tune With Earnings

Here's What Analysts Are Forecasting For Astrana Health, Inc. (NASDAQ:ASTH) After Its Third-Quarter Results

Nov 10
Here's What Analysts Are Forecasting For Astrana Health, Inc. (NASDAQ:ASTH) After Its Third-Quarter Results

Astrana Health, Inc.'s (NASDAQ:ASTH) P/E Is Still On The Mark Following 25% Share Price Bounce

Oct 04
Astrana Health, Inc.'s (NASDAQ:ASTH) P/E Is Still On The Mark Following 25% Share Price Bounce

Is Astrana Health, Inc. (NASDAQ:ASTH) Trading At A 21% Discount?

Sep 26
Is Astrana Health, Inc. (NASDAQ:ASTH) Trading At A 21% Discount?

Astrana Health's (NASDAQ:ASTH) Returns On Capital Not Reflecting Well On The Business

Sep 12
Astrana Health's (NASDAQ:ASTH) Returns On Capital Not Reflecting Well On The Business

Is Astrana Health (NASDAQ:ASTH) Using Too Much Debt?

Aug 28
Is Astrana Health (NASDAQ:ASTH) Using Too Much Debt?

Astrana Health, Inc.'s (NASDAQ:ASTH) 29% Jump Shows Its Popularity With Investors

Aug 02
Astrana Health, Inc.'s (NASDAQ:ASTH) 29% Jump Shows Its Popularity With Investors

Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?

Jun 19
Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?

Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal

Jun 02
Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal

Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

May 09
Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)

Apr 15
Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)

At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?

Feb 25
At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?

Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Feb 07
Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Apollo Medical Holdings: Good Company, Not Quite A Hold

Jan 17

With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For

Dec 27
With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For

Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled

Nov 08
Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled

Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?

Oct 26
Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?

Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet

Sep 22
Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet

Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down

Aug 04
Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down

A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

Jul 19
A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt

Jun 19
We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt

Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher

May 05
Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher

Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?

Apr 20
Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?

Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?

Mar 21
Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?

Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward

Jan 06
Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward

Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Dec 16
Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Shareholder Returns

ASTHUS HealthcareUS Market
7D-10.4%-4.1%-2.4%
1Y-11.2%-10.2%23.3%

Return vs Industry: ASTH matched the US Healthcare industry which returned -10.2% over the past year.

Return vs Market: ASTH underperformed the US Market which returned 23.3% over the past year.

Price Volatility

Is ASTH's price volatile compared to industry and market?
ASTH volatility
ASTH Average Weekly Movement7.8%
Healthcare Industry Average Movement7.6%
Market Average Movement6.3%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: ASTH has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: ASTH's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19851,800Brandon Simwww.astranahealth.com

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

Astrana Health, Inc. Fundamentals Summary

How do Astrana Health's earnings and revenue compare to its market cap?
ASTH fundamental statistics
Market capUS$1.66b
Earnings (TTM)US$62.46m
Revenue (TTM)US$1.72b

26.5x

P/E Ratio

1.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ASTH income statement (TTM)
RevenueUS$1.72b
Cost of RevenueUS$1.46b
Gross ProfitUS$259.89m
Other ExpensesUS$197.43m
EarningsUS$62.46m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.27
Gross Margin15.09%
Net Profit Margin3.63%
Debt/Equity Ratio86.4%

How did ASTH perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 01:40
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Astrana Health, Inc. is covered by 13 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hua HaBaird
Sarah JamesBarclays
Adam RonBofA Global Research